Last 12 months
Inside the activity.
1 purchase rows · 8 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 1 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 26, 2025 Filed Feb 26, 2025 20:30 UTC |
Duelks Robert NDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 4,107 | $0.00 Strike: $88.66 | $0.00 |
DisclosureSEC source: 0001225208-25-002457 · doc4.xml · derivative · entry 11 Duelks Robert N · CIK 0001477044 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,107 shares Expires 2027-11-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 26, 2025 Filed Feb 26, 2025 20:30 UTC |
Duelks Robert NDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,771 | $0.00 Strike: $56.37 | $0.00 |
DisclosureSEC source: 0001225208-25-002457 · doc4.xml · derivative · entry 10 Duelks Robert N · CIK 0001477044 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,771 shares Expires 2025-11-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 26, 2025 Filed Feb 26, 2025 20:30 UTC |
Duelks Robert NDirector
|
SaleCommon Stock | 3,141 | $237.15 | $744,898.20 |
DisclosureSEC source: 0001225208-25-002457 · doc4.xml · nonDerivative · entry 6 Duelks Robert N · CIK 0001477044 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,510 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $237.01 - $237.41, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. Read SEC document |
| February 26, 2025 Filed Feb 26, 2025 20:30 UTC |
Duelks Robert NDirector
|
SaleCommon Stock | 2,690 | $237.15 | $637,942.11 |
DisclosureSEC source: 0001225208-25-002457 · doc4.xml · nonDerivative · entry 5 Duelks Robert N · CIK 0001477044 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,651 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $237.01 - $237.41, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. Read SEC document |
| February 26, 2025 Filed Feb 26, 2025 20:30 UTC |
Duelks Robert NDirector
|
SaleCommon Stock | 2,574 | $237.15 | $610,432.34 |
DisclosureSEC source: 0001225208-25-002457 · doc4.xml · nonDerivative · entry 4 Duelks Robert N · CIK 0001477044 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,341 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $237.01 - $237.41, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. Read SEC document |
| February 26, 2025 Filed Feb 26, 2025 20:30 UTC |
Duelks Robert NDirector
|
Exercise / conversionCommon Stock | 4,107 | $88.66 | $364,126.62 |
DisclosureSEC source: 0001225208-25-002457 · doc4.xml · nonDerivative · entry 3 Duelks Robert N · CIK 0001477044 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,915 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 26, 2025 Filed Feb 26, 2025 20:30 UTC |
Duelks Robert NDirector
|
Exercise / conversionCommon Stock | 4,753 | $64.89 | $308,422.17 |
DisclosureSEC source: 0001225208-25-002457 · doc4.xml · nonDerivative · entry 2 Duelks Robert N · CIK 0001477044 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,808 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 26, 2025 Filed Feb 26, 2025 20:30 UTC |
Duelks Robert NDirector
|
Exercise / conversionCommon Stock | 5,771 | $56.37 | $325,311.27 |
DisclosureSEC source: 0001225208-25-002457 · doc4.xml · nonDerivative · entry 1 Duelks Robert N · CIK 0001477044 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,055 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 06, 2025 Filed Feb 6, 2025 18:49 UTC |
keller brettDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,771 | $0.00 Strike: $56.37 | $0.00 |
DisclosureSEC source: 0001225208-25-001319 · doc4.xml · derivative · entry 6 KELLER BRETT · CIK 0001214608 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,771 shares Expires 2025-11-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 06, 2025 Filed Feb 6, 2025 18:49 UTC |
keller brettDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,087 | $0.00 Strike: $51.43 | $0.00 |
DisclosureSEC source: 0001225208-25-001319 · doc4.xml · derivative · entry 5 KELLER BRETT · CIK 0001214608 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,087 shares Expires 2025-05-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 06, 2025 Filed Feb 6, 2025 18:49 UTC |
keller brettDirector
|
SaleCommon Stock | 3,566 | $240.40 | $857,266.76 |
DisclosureSEC source: 0001225208-25-001319 · doc4.xml · nonDerivative · entry 4 KELLER BRETT · CIK 0001214608 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,536 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $239.55 - $241.0763, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. Read SEC document |
| February 06, 2025 Filed Feb 6, 2025 18:49 UTC |
keller brettDirector
|
SaleCommon Stock | 1,876 | $240.40 | $450,990.59 |
DisclosureSEC source: 0001225208-25-001319 · doc4.xml · nonDerivative · entry 3 KELLER BRETT · CIK 0001214608 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,102 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $239.55 - $241.0763, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. Read SEC document |
| February 06, 2025 Filed Feb 6, 2025 18:49 UTC |
keller brettDirector
|
Exercise / conversionCommon Stock | 3,087 | $51.43 | $158,764.41 |
DisclosureSEC source: 0001225208-25-001319 · doc4.xml · nonDerivative · entry 2 KELLER BRETT · CIK 0001214608 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,978 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 06, 2025 Filed Feb 6, 2025 18:49 UTC |
keller brettDirector
|
Exercise / conversionCommon Stock | 5,771 | $56.37 | $325,311.27 |
DisclosureSEC source: 0001225208-25-001319 · doc4.xml · nonDerivative · entry 1 KELLER BRETT · CIK 0001214608 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,891 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 04, 2025 Filed Feb 5, 2025 17:11 UTC |
Ghei AshimaInterim CFO
|
GrantStock Option (Right to Buy) · Derivative | 14,137 | $0.00 Strike: $240.59 | $0.00 |
DisclosureSEC source: 0001225208-25-001232 · doc4.xml · derivative · entry 1 Ghei Ashima · CIK 0002028322 · Interim CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,137 Underlying: Common Stock · 14,137 shares Expires 2035-02-04 F1 · derivative.exercise_date: Stock options vest equally over 4 years beginning February 4, 2026. Read SEC document |
| February 04, 2025 Filed Feb 5, 2025 17:11 UTC |
Jarkowski Hope M.Chief Legal Officer
|
GrantStock Option (Right to Buy) · Derivative | 12,473 | $0.00 Strike: $240.59 | $0.00 |
DisclosureSEC source: 0001225208-25-001234 · doc4.xml · derivative · entry 1 Jarkowski Hope M. · CIK 0002024023 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,473 Underlying: Common Stock · 12,473 shares Expires 2035-02-04 F1 · derivative.exercise_date: Stock options vest equally over 4 years beginning February 4, 2026. Read SEC document |
| February 04, 2025 Filed Feb 5, 2025 12:11 UTC |
Matlin LauraCVP, Deputy GC and CCO
|
GrantStock Option (Right to Buy) · Derivative | 1,580 | $0.00 Strike: $240.59 | $0.00 |
DisclosureSEC source: 0001225208-25-001235 · doc4.xml · derivative · entry 2 Matlin Laura · CIK 0001658944 · CVP, Deputy GC and CCO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,580 Underlying: Common Stock · 1,580 shares Expires 2035-02-04 F1 · derivative.exercise_date: Stock options vest equally over 4 years beginning February 4, 2026. Read SEC document |
| February 04, 2025 Filed Feb 5, 2025 12:11 UTC |
Matlin LauraCVP, Deputy GC and CCO
|
SaleCommon Stock | 514 | $241.60 | $124,180.76 |
DisclosureSEC source: 0001225208-25-001235 · doc4.xml · nonDerivative · entry 1 Matlin Laura · CIK 0001658944 · CVP, Deputy GC and CCO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,601.696 Read SEC document |
| February 04, 2025 Filed Feb 5, 2025 17:11 UTC | GrantStock Option (Right to Buy) · Derivative | 110,601 | $0.00 Strike: $240.59 | $0.00 |
DisclosureSEC source: 0001225208-25-001233 · doc4.xml · derivative · entry 1 Gokey Timothy C · CIK 0001296187 · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 110,601 Underlying: Common Stock · 110,601 shares Expires 2035-02-04 F1 · derivative.exercise_date: Stock options vest equally over 4 years beginning February 4, 2026. Read SEC document |
|
| February 04, 2025 Filed Feb 5, 2025 12:11 UTC |
DALY RICHARD JDirector · Executive Chairman
|
GrantStock Option (Right to Buy) · Derivative | 4,241 | $0.00 Strike: $240.59 | $0.00 |
DisclosureSEC source: 0001225208-25-001230 · doc4.xml · derivative · entry 1 DALY RICHARD J · CIK 0001198860 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,241 Underlying: Common Stock · 4,241 shares Expires 2035-02-04 F1 · derivative.exercise_date: Stock options vest equally over 4 years beginning February 4, 2026. Read SEC document |
| February 04, 2025 Filed Feb 5, 2025 17:11 UTC |
Stingi Richard JohnCorporate VP and CHRO
|
GrantStock Option (Right to Buy) · Derivative | 7,068 | $0.00 Strike: $240.59 | $0.00 |
DisclosureSEC source: 0001225208-25-001237 · doc4.xml · derivative · entry 1 Stingi Richard John · CIK 0001846577 · Corporate VP and CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,068 Underlying: Common Stock · 7,068 shares Expires 2035-02-04 F1 · derivative.exercise_date: Stock options vest equally over 4 years beginning February 4, 2026. Read SEC document |
| February 04, 2025 Filed Feb 5, 2025 17:11 UTC |
PERRY CHRISTOPHER JOHNPresident
|
GrantStock Option (Right to Buy) · Derivative | 34,095 | $0.00 Strike: $240.59 | $0.00 |
DisclosureSEC source: 0001225208-25-001236 · doc4.xml · derivative · entry 1 PERRY CHRISTOPHER JOHN · CIK 0001619128 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,095 Underlying: Common Stock · 34,095 shares Expires 2035-02-04 F1 · derivative.exercise_date: Stock options vest equally over 4 years beginning February 4, 2026. Read SEC document |
| February 04, 2025 Filed Feb 5, 2025 17:11 UTC |
DESCHUTTER DOUGLAS RICHARDCo-President ICS
|
GrantStock Option (Right to Buy) · Derivative | 9,771 | $0.00 Strike: $240.59 | $0.00 |
DisclosureSEC source: 0001225208-25-001231 · doc4.xml · derivative · entry 1 DESCHUTTER DOUGLAS RICHARD · CIK 0001391093 · Co-President ICS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,771 Underlying: Common Stock · 9,771 shares Expires 2035-02-04 F1 · derivative.exercise_date: Stock options vest equally over 4 years beginning February 4, 2026. Read SEC document |
| February 04, 2025 Filed Feb 5, 2025 17:11 UTC |
Carey Thomas PCorporate VP
|
GrantStock Option (Right to Buy) · Derivative | 15,384 | $0.00 Strike: $240.59 | $0.00 |
DisclosureSEC source: 0001225208-25-001229 · doc4.xml · derivative · entry 1 Carey Thomas P · CIK 0001731499 · Corporate VP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,384 Underlying: Common Stock · 15,384 shares Expires 2035-02-04 F1 · derivative.exercise_date: Stock options vest equally over 4 years beginning February 4, 2026. Read SEC document |
| January 03, 2025 Filed Jan 10, 2025 20:29 UTC |
Duelks Robert NDirector
|
GrantCommon Stock | 77 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-000529 · doc4.xml · nonDerivative · entry 1 Duelks Robert N · CIK 0001477044 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,284 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| January 03, 2025 Filed Jan 10, 2025 20:29 UTC |
FLOWERS MELVIN LDirector
|
GrantCommon Stock | 8 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-000530 · doc4.xml · nonDerivative · entry 1 FLOWERS MELVIN L · CIK 0001196490 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,166 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| January 03, 2025 Filed Jan 10, 2025 20:29 UTC |
keller brettDirector
|
GrantCommon Stock | 13 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-000531 · doc4.xml · nonDerivative · entry 2 KELLER BRETT · CIK 0001214608 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,120 F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| January 03, 2025 Filed Jan 10, 2025 20:29 UTC |
keller brettDirector
|
GrantCommon Stock | 31 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-000531 · doc4.xml · nonDerivative · entry 1 KELLER BRETT · CIK 0001214608 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,107 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| January 03, 2025 Filed Jan 10, 2025 20:29 UTC |
MURRAY EILEEN KDirector
|
GrantCommon Stock | 4 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-000535 · doc4.xml · nonDerivative · entry 2 MURRAY EILEEN K · CIK 0001341752 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,148 F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| January 03, 2025 Filed Jan 10, 2025 20:29 UTC |
MURRAY EILEEN KDirector
|
GrantCommon Stock | 6 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-000535 · doc4.xml · nonDerivative · entry 1 MURRAY EILEEN K · CIK 0001341752 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,144 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| January 03, 2025 Filed Jan 10, 2025 20:29 UTC |
Zavery AmitDirector
|
GrantCommon Stock | 13 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-000534 · doc4.xml · nonDerivative · entry 2 Zavery Amit · CIK 0001781064 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,418 F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| January 03, 2025 Filed Jan 10, 2025 20:29 UTC |
Zavery AmitDirector
|
GrantCommon Stock | 14 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-000534 · doc4.xml · nonDerivative · entry 1 Zavery Amit · CIK 0001781064 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,405 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| January 03, 2025 Filed Jan 10, 2025 20:29 UTC |
Nazareth Annette L.Director
|
GrantCommon Stock | 8 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-000533 · doc4.xml · nonDerivative · entry 2 Nazareth Annette L. · CIK 0001846828 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,087 F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| January 03, 2025 Filed Jan 10, 2025 20:29 UTC |
Nazareth Annette L.Director
|
GrantCommon Stock | 8 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-000533 · doc4.xml · nonDerivative · entry 1 Nazareth Annette L. · CIK 0001846828 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,095 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| January 03, 2025 Filed Jan 10, 2025 20:29 UTC |
Markus Maura A.Director
|
GrantCommon Stock | 15 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-000532 · doc4.xml · nonDerivative · entry 2 Markus Maura A. · CIK 0001571545 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,465.102 F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| January 03, 2025 Filed Jan 10, 2025 20:29 UTC |
Markus Maura A.Director
|
GrantCommon Stock | 52 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-000532 · doc4.xml · nonDerivative · entry 1 Markus Maura A. · CIK 0001571545 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,450.102 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| January 03, 2025 Filed Jan 10, 2025 20:29 UTC |
Carter Pamela LDirector
|
GrantCommon Stock | 19 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-000528 · doc4.xml · nonDerivative · entry 1 Carter Pamela L · CIK 0001396958 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,145 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| December 16, 2024 Filed Dec 17, 2024 16:50 UTC |
keller brettDirector
|
GrantCommon Stock | 136 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-010870 · doc4.xml · nonDerivative · entry 1 KELLER BRETT · CIK 0001214608 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,076 F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| December 16, 2024 Filed Dec 17, 2024 16:50 UTC |
MURRAY EILEEN KDirector
|
GrantCommon Stock | 188 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-010872 · doc4.xml · nonDerivative · entry 1 MURRAY EILEEN K · CIK 0001341752 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,138 F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| December 16, 2024 Filed Dec 17, 2024 16:50 UTC |
Zavery AmitDirector
|
GrantCommon Stock | 136 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-010874 · doc4.xml · nonDerivative · entry 1 Zavery Amit · CIK 0001781064 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,391 F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| December 16, 2024 Filed Dec 17, 2024 16:50 UTC |
Nazareth Annette L.Director
|
GrantCommon Stock | 136 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-010873 · doc4.xml · nonDerivative · entry 1 Nazareth Annette L. · CIK 0001846828 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,079 F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| December 16, 2024 Filed Dec 17, 2024 16:50 UTC |
Markus Maura A.Director
|
GrantCommon Stock | 152 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-010871 · doc4.xml · nonDerivative · entry 1 Markus Maura A. · CIK 0001571545 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,398.102 F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| December 03, 2024 Filed Dec 4, 2024 16:24 UTC |
Carey Thomas PCorporate VP
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 15,167 | $0.00 Strike: $117.34 | $0.00 |
DisclosureSEC source: 0001225208-24-010522 · doc4.xml · derivative · entry 4 Carey Thomas P · CIK 0001731499 · Corporate VP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,167 shares Expires 2030-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 03, 2024 Filed Dec 4, 2024 16:24 UTC |
Carey Thomas PCorporate VP
|
SaleCommon Stock | 13,208 | $230.32 | $3,042,104.86 |
DisclosureSEC source: 0001225208-24-010522 · doc4.xml · nonDerivative · entry 3 Carey Thomas P · CIK 0001731499 · Corporate VP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,146 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $229.935 - $231.44, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. Read SEC document |
| December 03, 2024 Filed Dec 4, 2024 16:24 UTC |
Carey Thomas PCorporate VP
|
SaleCommon Stock | 2,502 | $230.32 | $576,267.90 |
DisclosureSEC source: 0001225208-24-010522 · doc4.xml · nonDerivative · entry 2 Carey Thomas P · CIK 0001731499 · Corporate VP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,354 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $229.935 - $231.44, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. Read SEC document |
| December 03, 2024 Filed Dec 4, 2024 16:24 UTC |
Carey Thomas PCorporate VP
|
Exercise / conversionCommon Stock | 15,167 | $117.34 | $1,779,695.78 |
DisclosureSEC source: 0001225208-24-010522 · doc4.xml · nonDerivative · entry 1 Carey Thomas P · CIK 0001731499 · Corporate VP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,856 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 21, 2024 Filed Nov 22, 2024 13:12 UTC |
DALY RICHARD JDirector · Executive Chairman
|
GiftCommon Stock | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-010109 · doc4.xml · nonDerivative · entry 1 DALY RICHARD J · CIK 0001198860 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 104,093.9949 F1 · kind: Represents shares of Common Stock that the reporting person donated as a gift to the Richard J Daly Foundation donor advised fund account. Read SEC document |
| November 14, 2024 Filed Nov 15, 2024 19:32 UTC |
Duelks Robert NDirector
|
GrantStock Option (Right to Buy) · Derivative | 1,844 | $0.00 Strike: $227.56 | $0.00 |
DisclosureSEC source: 0001225208-24-009962 · doc4.xml · derivative · entry 5 Duelks Robert N · CIK 0001477044 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,844 Underlying: Common Stock · 1,844 shares Expires 2034-11-14 F2 · derivative.exercise_date: Stock options vest immediately upon grant. Read SEC document |
| November 14, 2024 Filed Nov 15, 2024 19:32 UTC |
Duelks Robert NDirector
|
GrantCommon Stock | 458 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-009962 · doc4.xml · nonDerivative · entry 1 Duelks Robert N · CIK 0001477044 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,207 F1 · price: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan and represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| November 14, 2024 Filed Nov 15, 2024 19:32 UTC |
FLOWERS MELVIN LDirector
|
GrantStock Option (Right to Buy) · Derivative | 1,844 | $0.00 Strike: $227.56 | $0.00 |
DisclosureSEC source: 0001225208-24-009963 · doc4.xml · derivative · entry 2 FLOWERS MELVIN L · CIK 0001196490 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,844 Underlying: Common Stock · 1,844 shares Expires 2034-11-14 F2 · derivative.exercise_date: Stock options vest immediately upon grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.